Skip to content

A Comparison of Etomidate and Ketamine for Anesthesia Induction in Coronary Artery Bypass Graft Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01386229
Enrollment
40
Registered
2011-07-01
Start date
2011-03-31
Completion date
2012-03-31
Last updated
2011-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Surgery

Keywords

hemodynamic stability, etomidate, ketamine, coronary artery bypass surgery after induction of anesthesia, hemodynamic stability

Brief summary

The aim of this study is to determine whether ketamine is an acceptable alternative to etomidate for anesthesia induction in coronary artery bypass graft surgery in terms of hemodynamic stability and also to compare these agents regarding their effect on adrenal gland steroid synthesis in these patients.

Interventions

DRUGKetamine

During standard anesthesia induction with fentanyl and midazolam, ketamine 2 mg/kg IV will be administered

DRUGEtomidate

During standard anesthesia induction with fentanyl and midazolam, etomidate 3 mg/kg IV will be administered

Sponsors

Baskent University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for elective coronary artery bypass graft surgery with cardiopulmonary bypass * Patient's written informed consent for study participation * Ejection fraction ≥ 35%

Exclusion criteria

* Allergy to study drugs * Redo surgery

Design outcomes

Primary

MeasureTime frame
A more than 15% change in mean arterial pressure and heart rate after anesthesia inductionFor 60 minutes after anesthesia induction

Secondary

MeasureTime frameDescription
Adrenal gland steroid synthesis suppression24 hours and 5 days after study drug administrationA less than 9 microgram/dl increase in serum cortisol after stimulation with adrenocorticotropic hormone

Countries

Turkey (Türkiye)

Contacts

Primary ContactÖzgür Kömürcü
zgrkom@gmail.com+90 312 215 99 41
Backup ContactArash Pirat
araspirat@gmail.com+90 312 212 68 68

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026